Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 13;8(10):1672.
doi: 10.3390/jcm8101672.

Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation

Affiliations

Impact of Body Composition on the Risk of Hepatocellular Carcinoma Recurrence After Liver Transplantation

Karolina Grąt et al. J Clin Med. .

Abstract

Background: Body composition parameters are reported to influence the risk of hepatocellular carcinoma (HCC) recurrence after liver resection, yet data on patients undergoing liver transplantation are scarce. The aim of this study was to evaluate the impact of the amount of abdominal adipose tissue and skeletal muscles on the risk of HCC recurrence after liver transplantation.

Methods: This was a retrospective observational study performed on 77 HCC patients after liver transplantation. Subcutaneous fat area (SFA), visceral fat area, psoas muscle area and total skeletal muscle area were assessed on computed tomography on the level of L3 vertebra and divided by square meters of patient height. The primary outcome measure was five-year recurrence-free survival.

Results: Recurrence-free survival in the entire cohort was 95.7%, 90.8%, and 86.5% after one, three, and five years post-transplantation, respectively. SFA was significantly associated with the risk of HCC recurrence (p = 0.013), whereas no significant effects were found for visceral fat and skeletal muscle indices. The optimal cut-off for SFA for prediction of recurrence was 71.5 cm2/m2. Patients with SFA < 71.5 cm2/m2 and ≥71.5 cm2/m2 exhibited five-year recurrence-free survival of 96.0% and 55.4%, respectively (p = 0.001).

Conclusions: Excessive amount of subcutaneous adipose tissue is a risk factor for HCC recurrence after liver transplantation and may be considered in patient selection process.

Keywords: adipose tissue; computed tomography; hepatocellular carcinoma; liver transplantation; obesity; sarcopenia; subcutaneous fat; visceral fat.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study flowchart.
Figure 2
Figure 2
Examples of muscle and adipose tissue measurements: (a) Subcutaneous Fat Area (b) Visceral Fat Area (c) Psoas Major Area (d) Total Skeletal Muscle Area. (a) red zone represents Subcutaneous Fat Area, in this patient it was 332.6 cm2/m2 (b) red zone represents Visceral Fat Area, in this patient it was (138.9 cm2/m2) (c) red zone represents Psoas Major Area, in this patient it was 16.8 cm2/m2 (d) red zone represents Total Skeletal Muscle Area, in this patient it was 123.2 cm2/m2.
Figure 3
Figure 3
Recurrence-free survival after liver transplantation in HCC patients with (a) subcutaneous fat area <71.5cm2/m2 and ≥71.5cm2/m2 and (b) total fat area <90.5 cm2/m2 and ≥90.5 cm2/m2. . (a) Patients with the amount of subcutaneous fat area above the cut-off value had lower recurrence-free survival rates (b) Patients with the amount of total fat area above the cut-off value had lower recurrence-free survival rates.

Similar articles

Cited by

References

    1. Puigvehí M., Hashim D., Haber P.K., Dinani A., Schiano T.D., Asgharpour A., Kushner T., Kakked G., Tabrizian P., Schwartz M., et al. Liver Transplant for Hepatocellular Carcinoma in the United States: Evolving Trends over the Last Three Decades. Am. J. Transplant. 2019 doi: 10.1111/ajt.15576. - DOI - PMC - PubMed
    1. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., Montalto F., Ammatuna M., Morabito A., Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996;334:693–699. doi: 10.1056/NEJM199603143341104. - DOI - PubMed
    1. Grąt M., Wronka K.M., Stypułkowski J., Bik E., Krasnodębski M., Masior Ł., Lewandowski Z., Grąt K., Patkowski W., Krawczyk M. The Warsaw Proposal for the Use of Extended Selection Criteria in Liver Transplantation for Hepatocellular Cancer. Ann. Surg. Oncol. 2017;24:526–534. doi: 10.1245/s10434-016-5500-0. - DOI - PMC - PubMed
    1. Mazzaferro V., Sposito C., Zhou J., Pinna A.D., De Carlis L., Fan J., Cescon M., Di Sandro S., Yi-Feng H., Lauterio A., et al. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma. Gastroenterology. 2018;154:128–139. doi: 10.1053/j.gastro.2017.09.025. - DOI - PubMed
    1. Duvoux C., Roudot-Thoraval F., Decaens T., Pessione F., Badran H., Piardi T., Francoz C., Compagnon P., Vanlemmens C., Dumortier J., et al. Liver transplantation for hepatocellular carcinoma: A model including α-Fetoprotein improves the performance of Milan criteria. Gastroenterology. 2012;143:986–994. doi: 10.1053/j.gastro.2012.05.052. - DOI - PubMed

LinkOut - more resources